Comparative activities of beta-lactam antibiotics and quinolones for invasive Streptococcus pneumoniae isolates

Serkan Oncü1, Metin Punar, Haluk Eraksoy

  • 1Departments of Infectious Diseases and Clinical Microbiology, Adnan Menderes University Faculty of Medicine, Aydin, Turkey. serkanoncu@hotmail.com

Chemotherapy
|June 24, 2004
PubMed
Abstract

Insights

New quinolones like gemifloxacin and trovafloxacin show high activity against Streptococcus pneumoniae. These antibiotics hold promise for treating invasive pneumococcal infections, even those resistant to penicillin.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Streptococcus pneumoniae causes severe pneumonia and meningitis.
  • Invasive pneumococcal infections lead to significant mortality.
  • Antibiotic resistance in S. pneumoniae is a growing concern.

Purpose of the Study:

  • To evaluate the in vitro activity of five quinolones against invasive pneumococcal isolates.
  • To compare the efficacy of new quinolones with existing antibiotics.
  • To assess the impact of penicillin resistance on quinolone effectiveness.

Main Methods:

  • Broth microdilution method used to determine Minimum Inhibitory Concentrations (MICs).
  • Tested antibiotics included penicillin G, cefuroxime, azithromycin, clarithromycin, trimethoprim-sulfamethoxazole (SXT), ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin, and gemifloxacin.
  • Eighty-five invasive pneumococcal isolates were analyzed.

Main Results:

  • High resistance rates observed for penicillin (46%) and SXT (46%).
  • Gemifloxacin and trovafloxacin demonstrated the highest in vitro activity among the tested quinolones.
  • Penicillin resistance did not affect the susceptibility patterns to the new quinolones.

Conclusions:

  • New quinolones exhibit potent activity against both penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
  • Gemifloxacin and trovafloxacin represent promising therapeutic options for invasive pneumococcal diseases.
  • Further investigation into novel quinolones is warranted for combating antibiotic resistance.

Related Concept Videos

Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...